-
CMS’s 2015 ACO Performance Data Confirms: Newer ACO Models Are More Attractive
Learn about the different tracks and why we think MSSP Track 3 and Next Generation ACO promise much higher returns than Track 1.
-
Loading More...
Nico Lewine is Evolent Health's Managing Director of Clinical Research and Development. Nico has served many of Evolent’s partners in developing system-level strategies, with particular focus on Medicare programs such as Next Generation ACO, MSSP, CPC+, and more. Prior to joining Evolent in early 2014, Nico was an Engagement Manager at a boutique healthcare consultancy in Boston. He received his BA in Molecular & Cellular Biology from Harvard University.
Learn about the different tracks and why we think MSSP Track 3 and Next Generation ACO promise much higher returns than Track 1.